ClinicalTrials.gov
public full text
Public Domain
Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject
Y-4 is a new fixed-dose combination drug product containing two active ingredients of pregabalin and riluzole. The objective of the trial is to compare pharmacokinetic characteristics of Y-4 tablets with pregabalin capsules (Lyrica®) and riluzole tablets (Rilutek®) in Chinese healthy adult subjects after single oral administration under fasted condition.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects#1139424
- A Phase I Study of YY-20394 in Patients With B Cell Hematologic Malignancies#869171
- Clinical Study With Lyrica In Patients Suffering From Epilepsy#856010
- Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions#1032593
- Y-3 for Injection in the Treatment of Acute Ischemic Stroke#808055
Record · ID 880758
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive